Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Pharmacokinetic and Safety Profile of QID Dosing of Mibefradil in Normal Human Volunteers

NCT01550458 is registered in ClinicalTrials.gov with Cavion, Inc. as lead sponsor.

NCT NCT01550458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01550458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Pharmacokinetic and Safety Profile of QID Dosing of Mibefradil in Normal Human Volunteers
Lead sponsor
Cavion, Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2012
Completion date
June 24, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy